Addus HomeCare Insider Grant: 1,172 Shares Awarded to Director

Rhea-AI Filing Summary

Form 4 filing overview – Addus HomeCare Corp. (ADUS)

Director Darin J. Gordon reported the grant of 1,172 restricted common shares on 18-Jun-2025. The award was received at $0 cost under a standard non-employee director compensation plan and will vest in full on 18-Jun-2026. Following the grant, Gordon’s direct ownership rises to 12,795 ADUS shares.

No derivative securities were reported, and there were no sales or open-market purchases. The filing represents routine equity compensation intended to align the director’s interests with shareholders and does not signal a change in company fundamentals.

Positive

• Director’s equity stake increases by 1,172 shares, modestly strengthening alignment with shareholder interests.

Negative

• None.

Insights

Securities Analyst

TL;DR: Routine director grant; neutral impact.

The 1,172-share restricted stock award is typical annual compensation for Addus HomeCare’s outside directors. At today’s market price (~$95 per share), the grant is worth roughly $111k, immaterial to the company’s $1.5 bn market cap. Because the award vests over one year and involves no open-market buying or selling, it does not alter the supply–demand balance or signal insider sentiment. The filing is therefore informational rather than market-moving.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Gordon Darin J.

(Last) (First) (Middle)

6303 COWBOYS WAY

SUITE 600

(Street)

FRISCO TX 75034

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Addus HomeCare Corp [ ADUS ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/18/2025		A		1,172(1)	A	$0	12,795	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Restricted shares granted to non-employee directors that will vest in full on June 18, 2026.

	/s/ Brian Poff, Attorney-In-Fact for Darin J. Gordon	06/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What did director Darin J. Gordon report in the Form 4 for ADUS?

He received 1,172 restricted common shares on 18-Jun-2025 at $0 cost.

When will the newly granted ADUS restricted shares vest?

The shares will vest in full on 18-Jun-2026.

How many Addus HomeCare shares does Gordon own after the transaction?

His direct beneficial ownership is 12,795 shares.

Did the filing include any sales of ADUS shares?

No. The filing reports only an acquisition via a restricted stock grant.

Does this Form 4 filing impact Addus HomeCare’s fundamentals?

It is a routine compensation grant and does not affect the company’s financial fundamentals.